BBIO · Transaction May 11, 2026 · Filed Jun 8, 2026 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · BBIO
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
BridgeBio Pharma Inc
Biotechnology
$79.89
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET · BBIO
MethodologyBBIO
BridgeBio Pharma Inc
Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
SELL BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
39/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BBIO moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BridgeBio Pharma Inc
PHARMACEUTICAL PREPARATIONSListed since
2019
Employees
839
Country
US
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$79.89
Last session
Day high
$79.89
Last session
Day low
$79.89
Last session
Previous close
$79.89
52W high
$90.17
-11.40% from high
52W low
$47.29
76% of range
Market cap
$15.6B
EPS
$-3.4500
Beta
0.64
Shares out
195.5M
Avg volume
3M
VWAP
$79.89
Last session
Price history computed in-house
1W
-4.55%
1M
-1.83%
3M
+17.11%
1Y
+62.97%
YTD
+4.45%
SMA 50 $77.44 · above
SMA 200 $72.79 · above
52W position 76%
BBIO overview
Related filings and maps
Public disclosures
Congress activity in BBIO
Official filing ↗
BBIO · Transaction Apr 29, 2026 · Filed May 8, 2026 · $1,001 to $15,000
Bank of America BridgeBio Pharma, Inc. - Common Stock · Transaction Apr 14, 2026 · Filed Date unavailable · $1,001 to $15,000
BBIO · Transaction Mar 19, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
BBIO · Transaction Mar 18, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
Federal contracts
BBIO contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BBIO in this window.
Lobbying spend
BBIO lobbying filings, year to date.
Registered lobbying filings matched to BridgeBio Pharma Inc.
$1.8M
Refresh interval: 12hSource: LDA disclosure filings
Pharmacy
Filing
$500.0K
BRIDGEBIO PHARMA INC.
BRIDGEBIO PHARMA, INC.
Jul 20, 2026
Filing
$420.0K
BRIDGEBIO PHARMA INC.
BRIDGEBIO PHARMA, INC.
Apr 20, 2026
Filing
$330.0K
BRIDGEBIO PHARMA INC.
BRIDGEBIO PHARMA, INC.
Jul 17, 2026
Analyst ratings
Sovereign unlock shows live analyst consensus for BBIO.
Options
Sovereign unlock shows live options positioning for BBIO.